<DOC>
	<DOCNO>NCT00839800</DOCNO>
	<brief_summary>The primary objective study compare efficacy Symbicort SMART ( Symbicort Turbuhaler 160/4.5μg , one inhalation twice daily plus need ) Symbicort Turbuhaler 160/4.5μg , one inhalation twice daily plus terbutaline Turbuhaler 0.4 mg need , asthma therapy</brief_summary>
	<brief_title>Study Investigate Efficacy Symbicort® SMART .</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<criteria>Diagnosis asthma accord Global Initiative Asthma guideline ( GINA ) 2007 documented history least 6 month duration . Reversible airway obstruction , define increase FEV1 ≥12 % relative baseline patient 1530 minute inhalation total 2 x 0.4 mg terbutaline Turbuhaler Prescribed use inhale glucocorticoid steroid ( GCS ) ( brand ) least 12 week . Respiratory infection affect asthma , judge investigator , within 4 week . Intake oral , rectal parenteral GCS within 4 week and/or depot parenteral GCS within 12 week .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Symbicort Turbuhaler</keyword>
</DOC>